Sekhri Paul J
SEC-identified person · CIK 1264519 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Veeva Systems INC VEEV | Director | filed 2014 - 2026 |
| vTv Therapeutics Inc. VTVT | Director · President and CEO | filed 2022 - 2026 |
| Longboard Pharmaceuticals, Inc. LBPH | Director | filed 2021 - 2024 |
| Axcella Health Inc. AXLA | Director | filed 2022 - 2022 |
| Chardan Healthcare Acquisition Corp. PHGE] | Director | filed 2020 - 2021 |
| Nivalis Therapeutics, Inc. NVLS | Director | filed 2016 - 2020 |
| Enumeral Biomedical Holdings, Inc. ENUM | Director | filed 2015 - 2016 |
| Aryx Therapeutics, Inc. ARYX | Director | filed 2007 - 2010 |
| Biodel Inc BIODEL | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.